Back to Search
JAY SCHECHTMAN, M.D.
M.D.
Internal Medicine Physician
NPI: 1134231657Individual
Specialties, Licenses & Credentials
Research & Publications (8)
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
PMID 18759293·Arthritis Rheum·2008
3-trial
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
PMID 16649186·Arthritis Rheum·2006
3-trial
Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
PMID 16396977·Ann Rheum Dis·2006
4-observational
The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions.
PMID 15188350·Arthritis Rheum·2004
3-trial
Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
PMID 15088288·J Rheumatol·2004
3-trial
A critical intramolecular interaction for protein kinase Cepsilon translocation.
PMID 14739299·J Biol Chem·2004
7-preclinical
Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.
PMID 14530224·Ann Intern Med·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3461 AUSTIN PEAY HWY
MEMPHIS, TN 38128 - Phone
- (901) 261-4500
Quick Facts
- NPI
- 1134231657
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile